HOME >> BIOLOGY >> NEWS
Vion's TAPET Organisms Demonstrate Reduced Virulence, Increased Safety While Retaining Ability To Specifically Target Tumors

Genetically Modified Salmonella Lack Ability to Induce TNF-Alpha and Cause Sepsis According to Nature Biotechnology Publication

NEW HAVEN, CT (December 29, 1998): New research demonstrates that genetic modification of a cell wall component of tumor-targeting Salmonella bacteria can greatly reduce the bacteria's potential for virulence and ability to cause septic shock, announced Vion Pharmaceuticals, Inc. (Nasdaq: VION). Vion is developing the modified bacteria, the heart of the company's TAPET technology, as vectors for the targeted, systemic delivery of anti-cancer agents to tumors throughout the body.

A publication detailing the research, entitled "Lipid A mutant Salmonella with suppressed virulence and TNF-alpha induction retain tumor-targeting in vivo," will appear in the January issue of the journal Nature Biotechnology. The article is authored by scientists at Vion and their collaborators at Yale University School of Medicine; Texas A&M University, College of Veterinary Medicine; and the University of Washington Health Sciences Center.

Vion researchers and their collaborators have previously reported the development of Salmonella that specifically target tumors over normal tissues. However the clinical utility of such bacteria was potentially limited by the ability of lipid A in the bacteria's cell walls to elicit the production of TNF-alpha and trigger septic shock. Now the researchers have shown that a disruption of the Salmonella msbB gene involved in the production of lipid A reduces, by 10,000 fold, the ability of the bacteria's lipid to induce TNF-alpha and cause death in animal models. At the same time, the msbB-minus Salmonella retain their tumor-targeting properties, exhibiting the ability to accumulate in tumors at ratios in excess of 1000:1 compared with normal tissues.

"Administration of these modified bacteria to mice bearing melanoma tumors results in tumors that are less than six percent the size of tumors in unt
'"/>

Contact: Joan Kureczka
JKureczka@aol.com
415-821-2413
Kureczka/Martin Associates
29-Dec-1998


Page: 1 2 3 4

Related biology news :

1. Vions TAPET® administered to first patients in Phase I human intratumoral safety trial at the Cleveland Clinic Foundation
2. Software Helps Decipher Genomes Of Higher Organisms
3. The Fire Down Below: Extreme Heat-Loving Organisms May Be Keys To Molecular Evolution, Origin Of Life, New Book Argues
4. Virginia Tech Scientists To Evaluate Risks Associated With Release of Recombinant Organisms
5. Transposable Elements May Have Had A Major Role In The Evolution Of Higher Organisms
6. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
7. Emory University Scientists Demonstrate New Pathway For Genetic Mutations In Everyday Cell Life
8. Wake Forest Physicians Demonstrate How Gene-Diet Interaction Affects Cholesterol Absorption
9. Ribozyme Pharmaceuticals, Inc. Demonstrates Potent Activity Of A Ribozyme Targeted Against The Hepatitis C Virus
10. Engineering Animation, Inc. Demonstrates Internet Anatomy At Visible Human Project Conference
11. Study Demonstrates High Conservation Potential Of Logged Rainforest

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/27/2019)... ... August 27, 2019 , ... e3 Diagnostics, the nation’s ... it has partnered with Bertec, a leading manufacturer of force measurement devices for ... a full line of clinical systems for both assessment and treatment of balance ...
(Date:8/23/2019)... ... August 22, 2019 , ... R121 solidifies its place within ... of 2018. Along with the name change, this rebranding includes a comprehensive redesign ... create a cohesive brand that blended our core foundation of genuine ‘one-to-one’ relationships ...
(Date:8/15/2019)... LONDON (PRWEB) , ... August 15, 2019 , ... ... launch of their Food and Agriculture practice, a new unit dedicated to building 100 ... in sustainable nutrition, raw materials and supply chains. , Deep Science Ventures was ...
Breaking Biology News(10 mins):
(Date:8/14/2019)... ... August 13, 2019 , ... ... focus on prepackaged mobile phases for QC laboratories. After gaining a few significant ... laboratory sciences approach into a valued supplier of manufacturing processing solutions, including reagents ...
(Date:8/6/2019)... ... 2019 , ... Shoreline Biome, a microbiome research ... has announced partnerships with six international distributors. , The distributors will sell ... Australia, Benelux, Indonesia, Korea, Malaysia, Myanmar, New Zealand, Singapore, the United Kingdom, and ...
(Date:7/30/2019)... ... July 30, 2019 , ... ... building and cooking events company. Not only has the company already hosted many ... offering Private Cooking Parties to its guests. , With Lajollacooks4u’s Private Cooking Parties, ...
(Date:7/19/2019)... ... July 18, 2019 , ... World renowned ... be joining forces with California-based charity Coalition Duchenne for its 9th Annual Expedition ... raises awareness and funding for Duchenne muscular dystrophy and was founded by Sabahan ...
Breaking Biology Technology:
Cached News: